Freenome, Inc. (FRNM) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Freenome, Inc. (FRNM) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $120.6M, listed on NASDAQ, employing roughly 378 people, carrying a beta of 0.35 to the broader market. Freenome is an early cancer detection company developing blood-based screening tests to identify cancer in its earliest, most treatable stages. Led by Aaron Elliott, public since 2026-07-21.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for FRNM as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →